International Psoriasis Council

Advancing Knowledge. Improving Care.

Getting to Know IPC’s Board Member Claudia de la Cruz: What Inspired Me to Specialize in Psoriasis

Claudia de la Cruz, MD

Clinica Dermacross

Santiago, Chile

IPC Vice President/President-Elect

Bio
  • Dr. Claudia de la Cruz, based in Santiago, Chile, is the Secretary of the International Psoriasis Council and Founder and Director of Clínica Dermacross.
  • She earned her degree at Universidad de Chile and served as an Assistant Professor at Pontificia Universidad Católica de Chile from 2005 to 2013.
  • Throughout her career, she has focused on advocating for psoriasis in Chile and Latin America, leading initiatives such as the IPC Latin American Working Group and contributing to projects like PsoProtect.
  • She has been a Board Member of the International Psoriasis Council since 2017 and is a regional coordinator for Latin America for the Global Psoriasis Atlas (GPA).

Join us as we sit down with Dr. Claudia de la Cruz for an intimate discussion on her journey in dermatology, why she specialized in psoriasis, her advocacy work in Chile and Latin America, and her invaluable contributions to global psoriasis initiatives.

“I think that the IPC has really been one of the most important aspects in my life as a dermatologist dedicated to psoriasis.”

— Claudia de la Cruz, MD, Secretary

Categories

Recent Posts

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

Fellow Perspectives | Psoriasis Care in Ethiopia: Challenges and Opportunities for Progress

What Matters Most to People with Psoriasis? IPC Members Help Shape a Global Answer

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026